Signify Premium Insight: Accounting for Improved AI
Published: October 28, 2022
In Signify Research’s AI in Medical Imaging – World Market Analysis 2022 the main barriers stymieing the adoption of medical imaging AI were identified and assessed. One of the barriers that was identified as being most impactful was AI’s “lack of real-world evidence demonstrating the health economic benefits, including return on investment, for providers”.
The significance of this barrier is easy to understand. While providers are often keen to have the latest technology, and claims of clinical performance, even when validated by studies, can be compelling, hospitals will be reluctant to commit to any investments that don’t offer a clear or immediate return on investment. As highlighted in a recent Premium Insight, some vendors are
Read the full insight with a Signify Premium Insights – Medical Imaging subscriptionSign up for a free trial today.
AI in Medical Imaging Market Intelligence ServiceOngoing series of reports, data and insights delivered over the year
AI in Medical Imaging Market Intelligence Service
This Market Intelligence Service provides regular data, insights and analysis on the global market opportunity for AI-based medical image analysis.
Find out more